Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.
Pagadala MS, Lynch J, Karunamuni R, Alba PR, Lee KM, Agiri FY, Anglin T, Carter H, Gaziano JM, Jasuja GK, Deka R, Rose BS, Panizzon MS, Hauger RL, Seibert TM.
Pagadala MS, et al. Among authors: deka r.
J Natl Cancer Inst. 2023 Feb 8;115(2):190-199. doi: 10.1093/jnci/djac199.
J Natl Cancer Inst. 2023.
PMID: 36305680
Free PMC article.